Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Craniopharyngiomas.

Niki Karavitaki1, Simon Cudlip, Christopher B T Adams

  • 1Department of Endocrinology, Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, Old Road, Headington, Oxford OX3 7LJ, United Kingdom.

Endocrine Reviews
|March 18, 2006
PubMed
Summary

Craniopharyngiomas are rare tumors affecting children and adults. Optimal treatment is challenging due to unpredictable growth and lack of trials, necessitating research into prognostic factors and improved quality of life.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Consensus on acromegaly complications: an update.

Pituitary·2026
Same author

Impulse control disorders and dopamine agonists.

Best practice & research. Clinical endocrinology & metabolism·2026
Same author

Distribution, severity, and management of joint pain in patients with acromegaly.

European journal of endocrinology·2026
Same author

Management of endocrine disease: update on the management of pituitary apoplexy.

European journal of endocrinology·2026
Same author

Approach to the Patient with Cushing's Syndrome: Use of Anticoagulation Therapy.

The Journal of clinical endocrinology and metabolism·2025
Same author

Patient perceptions of pituitary incidentaloma diagnosis and follow-up: a Pituitary Society international patient survey.

Pituitary·2025

Area of Science:

  • Neuro-oncology
  • Endocrinology
  • Pediatric Oncology

Background:

  • Craniopharyngiomas are rare sellar/parasellar epithelial tumors with two subtypes: adamantinomatous and papillary.
  • Pathogenesis remains unclear, presenting with diverse neurological, visual, and hypothalamo-pituitary manifestations.
  • Benign histology belies unpredictable growth, complicating therapeutic protocol development.

Purpose of the Study:

  • To review current understanding and challenges in managing craniopharyngiomas.
  • To highlight the need for improved therapeutic strategies focusing on recurrence prevention, survival, morbidity reduction, and quality of life.
  • To emphasize the importance of identifying prognostic factors for better patient outcomes.

Main Methods:

  • Review of existing literature on craniopharyngioma diagnosis, treatment, and outcomes.

Related Experiment Videos

  • Discussion of current therapeutic options including surgery, radiotherapy, and alternative approaches.
  • Exploration of the difficulties in predicting prognosis and the potential role of central patient registration.

    • Main Results:

    • Current primary treatment involves surgical excision followed by irradiation for residual tumors.
    • Alternative treatments like intracystic irradiation, radiosurgery, and chemotherapy exist but require further evaluation in robust trials.
    • Identifying clinical and imaging parameters for prognosis prediction remains a significant challenge.

    Conclusions:

    • Optimal craniopharyngioma management requires a focus on preventing recurrence, improving survival, minimizing morbidity, and preserving quality of life.
    • Further adequately powered long-term trials are needed to assess the role of alternative treatment modalities.
    • Centralized patient registration and identification of pathological or molecular prognostic factors are crucial for future therapeutic guidance.